The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Recall does not include any metabolic deficiency nutrition formulas
Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
Subscribe To Our Newsletter & Stay Updated
